Tommy Wood

speaker

390 appearances 1 recordings 1 series first heard Apr 2026 last heard 12 Apr

Tommy Wood’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Apr 2026 with 1.

Appearances

newest first · ▶ plays the moment

The mindbodygreen Podcast · 645: The truth about cognitive decline and what you can do about it | Tommy Wood, M.D., Ph.D. · 12 Apr 2026 podcast

You're the expert, you tell me.

So I have a lot of hope that

these biomarkers will become more useful over time of course i want people to have as much information as possible and it to be actionable i think that's the most important the information is actionable and and that's where the gap really exists right now there's been some very nice discussion about this in the academic literature there was one paper called i think it was the tyranny of biomarkers um and they which i which i really liked and they made this point that

We're developing these biomarkers largely because A, they're things we can measure and B, they're things that we can potentially modify with drugs, but they're not necessarily the things that actually matter when it comes to improving treatment and quality of life and disease progression for the patient.

So there's this disconnect between the biomarkers we're developing and what actually matters for the individual.

And hopefully those things will align.

But right now you see lots of people testing these things

And we don't really know what to do.

What's quote unquote normal?

What's benign?

What do we do if a biomarker is elevated, but you're doing everything right and you display no symptoms and have nothing really to be concerned about?

And right now, we just genuinely don't know.

So this will come over time, but...

I think that the thing that we can focus on right now is we know so much about the significant risk factors for cognitive decline and dementia.

We know that they're modifiable.

We know that if we address those, we could potentially dramatically decrease dementia burden.

And that's in the absence of having to test any biomarkers.

But maybe we test these things, and that makes people engage in these activities.

They take their metabolic health more seriously.

They take their physical activity more seriously.

Showing 1–20 of 390 · page 1 of 20